Ledelse og eierskap · ENTRANS INVEST AS
Eiere
Selskapet eier
| Selskap | Org.nr. | Andel | Registerår |
|---|---|---|---|
| ENTRANS AS | 979 217 072 | 100,0 % | 2025 |
| GSH HOLDING AS | 919 631 392 | 3,5 % | 2024 |
| DST HOLDING AS | 927 009 978 | 3,1 % | 2023 |
| HEIDRUN HOLDING AS | 921 012 462 | 2,9 % | 2024 |
| FINTECH NEO GROUP AS | 917 135 371 | 1,5 % | 2025 |
| FLEXM GLOBAL AS | 919 945 915 | 0,9 % | 2025 |
| GONDOLIN AS | 921 572 204 | 0,7 % | 2023 |
| NORTH PRIVATE EQUITY AS | 928 987 035 | 0,4 % | 2024 |
| HOFSETH BIOCARE ASA | 994 464 663 | 0,3 % | 2025 |
| CLEAN FISH GROUP AS | 923 584 609 | 0,2 % | 2025 |
| GFJORD INVEST AS | 998 602 734 | 0,1 % | 2025 |
| NORBECO AS | 824 783 292 | 0,1 % | 2024 |
| DEPO SOLUTIONS AS | 826 019 212 | 0,1 % | 2025 |
| NORWEGIAN CRYSTALS ASA | 925 323 004 | 0,0 % | 2022 |
| DOF ASA | 935 349 230 | 0,0 % | 2024 |
| QUANTAFUEL AS | 915 119 484 | 0,0 % | 2023 |
| GC RIEBER SHIPPING HOLDING AS | 987 974 532 | 0,0 % | 2022 |
| PCI BIOTECH HOLDING ASA | 991 036 393 | 0,0 % | 2025 |
| ATLANTIC SAPPHIRE AS | 895 436 232 | 0,0 % | 2025 |
| NYKODE THERAPEUTICS ASA | 990 646 066 | 0,0 % | 2025 |
| NEXT BIOMETRICS GROUP ASA | 982 904 420 | 0,0 % | 2025 |
| VOIM ASA | 984 195 486 | 0,0 % | 2021 |
| SAGA PURE ASA | 995 359 774 | 0,0 % | 2020 |
| ARCTICZYMES TECHNOLOGIES ASA | 959 033 560 | 0,0 % | 2020 |
| BELSHIPS AS | 930 776 793 | 0,0 % | 2024 |
Kilde: Skatteetatens aksjonærregister, hentet 31.07.2026 · Hele konsernet → · Hele porteføljen →